almost significantP = 0.0506
The DOP agonist Deltorphin II, on the contrary, showed an almost significant reduction of the PKA-II activity at 20 μM ( P = 0.0506), but not at 10 μM (Fig. 6 E).
The DOP agonist Deltorphin II, on the contrary, showed an almost significant reduction of the PKA-II activity at 20 μM ( P = 0.0506), but not at 10 μM (Fig. 6 E).
By contrast, stimulation of hiPSCdNs with the GPCR ligands, serotonin (5-HT), and cicaprost (Cic, more stable prostacyclin PGI2 analogue) resulted in no significant pRII responses, although a slight trend towards increased responses was detectable after longer maturation times (Figs. 5 C and D).